147 related articles for article (PubMed ID: 18518851)
1. Pharmacogenetics of bone treatments: the VDR and ERalpha gene story.
Massart F; Marcucci G; Brandi ML
Pharmacogenomics; 2008 Jun; 9(6):733-46. PubMed ID: 18518851
[TBL] [Abstract][Full Text] [Related]
2. Human races and pharmacogenomics of effective bone treatments.
Massart F
Gynecol Endocrinol; 2005 Jan; 20(1):36-44. PubMed ID: 15969245
[TBL] [Abstract][Full Text] [Related]
3. Genetics and pharmacogenetics of osteoporosis.
Carbonell Sala S; Masi L; Marini F; Del Monte F; Falchetti A; Franceschelli F; Brandi ML
J Endocrinol Invest; 2005; 28(10 Suppl):2-7. PubMed ID: 16550715
[TBL] [Abstract][Full Text] [Related]
4. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
5. Bone mass pharmacogenetics and ethnic health implications.
Massart F; Brandi ML
Clin Cases Miner Bone Metab; 2007 May; 4(2):131-8. PubMed ID: 22461213
[TBL] [Abstract][Full Text] [Related]
6. The bone mass density in postmenopausal women using hormonal replacement therapy in relation to polymorphism in vitamin D receptor and estrogen receptor genes.
Brodowska A; Starczewski A; Brodowski J; Szydłowska I; Nawrocka-Rutkowska J
Gynecol Endocrinol; 2009 May; 25(5):315-23. PubMed ID: 19903038
[TBL] [Abstract][Full Text] [Related]
7. Update on the pharmacogenetics of the vitamin D receptor and osteoporosis.
Gennari L; Merlotti D; De Paola V; Martini G; Nuti R
Pharmacogenomics; 2009 Mar; 10(3):417-33. PubMed ID: 19290791
[TBL] [Abstract][Full Text] [Related]
8. Genomic and metabolomic patterns segregate with responses to calcium and vitamin D supplementation.
Elnenaei MO; Chandra R; Mangion T; Moniz C
Br J Nutr; 2011 Jan; 105(1):71-9. PubMed ID: 20727239
[TBL] [Abstract][Full Text] [Related]
9. Genetics of osteoporosis.
Ralston SH
Ann N Y Acad Sci; 2010 Mar; 1192():181-9. PubMed ID: 20392235
[TBL] [Abstract][Full Text] [Related]
10. Tissue-specific effect of VDR gene polymorphisms on the response to calcitriol.
Alvarez-Hernandez D; Naves-Diaz M; Gomez-Alonso C; Coto E; Cannata-Andia JB
J Nephrol; 2008; 21(6):843-9. PubMed ID: 19034868
[TBL] [Abstract][Full Text] [Related]
11. Genetics of osteoporosis.
Eisman JA
Endocr Rev; 1999 Dec; 20(6):788-804. PubMed ID: 10605626
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of osteoporosis and the prospect of individualized prognosis and individualized therapy.
Nguyen TV; Center JR; Eisman JA
Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):481-8. PubMed ID: 18971675
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of estrogen receptor-alpha: possible implications for targeted osteoporosis therapy.
Ongphiphadhanakul B
Am J Pharmacogenomics; 2003; 3(1):5-9. PubMed ID: 12562211
[TBL] [Abstract][Full Text] [Related]
14. [Bone density and bone metabolism regulated by vitamin D receptor allele polymorphism in a German study sample].
Baltzer AW; Reinecke J; Wehling P; Granrath M; Schulitz KP
Z Orthop Ihre Grenzgeb; 1999; 137(3):273-9. PubMed ID: 10441835
[TBL] [Abstract][Full Text] [Related]
15. The genetics of osteoporosis: vitamin D receptor polymorphisms.
Wood RJ; Fleet JC
Annu Rev Nutr; 1998; 18():233-58. PubMed ID: 9706225
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between the polymorphism of start codon and CDX2 site in vitamin D receptor gene and the effect of calcium supplementation on bone mineral density of postmenopausal women].
Zhang ZL; He JW; Huang QR; Qin YJ; Hu YQ; Li M; Zhang H; Liu YJ; Hu WW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Aug; 23(4):397-401. PubMed ID: 16883525
[TBL] [Abstract][Full Text] [Related]
17. [Advances in the research of vitamin D receptor gene].
Xu B; Wang BJ
Fa Yi Xue Za Zhi; 2005 Feb; 21(1):55-7, 60. PubMed ID: 15895809
[TBL] [Abstract][Full Text] [Related]
18. [Relationships among vitamin D receptor gene and calcium absorption, bone mass].
Tong ZQ; Ma GS
Wei Sheng Yan Jiu; 2006 May; 35(3):370-3. PubMed ID: 16921772
[TBL] [Abstract][Full Text] [Related]
19. [Vitamine D in patients with osteoporosis: sufficient or necessary?].
Ferrari S
Rev Med Suisse; 2007 Jun; 3(115):1515-6, 1518-20. PubMed ID: 17682795
[TBL] [Abstract][Full Text] [Related]
20. Do the COL1A1 and Taq 1 vitamin D receptor polymorphisms have a role in identifying individuals at risk of developing osteoporosis?
McClean E; Archbold GP; Taggart HM
Ulster Med J; 2003 May; 72(1):26-33. PubMed ID: 12868700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
